Chemical Proteomic Discovery of Isotype‐Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2
Angewandte Chemie International Edition · 18.12.2023 · 62 (51)
DOI: 10.1002/anie.202311924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 14.11.2023. Verfasst von Yongfeng Tao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550N. Torrey Pines Road, La Jolla, CA-92307,…. Hauptthemen laut MEDLINE: Azetidines, Methyltransferases, tRNA Methyltransferases, Enzyme Inhibitors. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NHGRI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
5‐Methylcytosine (m 5 C) is an RNA modification prevalent on tRNAs, where it can protect tRNAs from endonucleolytic cleavage to maintain protein synthesis. The NSUN family (NSUN1‐7 in humans) of RNA methyltransferases are capable of installing the methyl group onto the C 5 position of cytosines in RNA. NSUNs are implicated in a wide range of (patho)physiological processes, but selective and cell‐active inhibitors of these enzymes are lacking. Here, we use cysteine‐directed activity‐based protein profiling (ABPP) to discover azetidine acrylamides that act as stereoselective covalent inhibitors of human NSUN2. Despite targeting a conserved catalytic cysteine in the NSUN family, the NSUN2 inhibitors show negligible cross‐reactivity with other human NSUNs and exhibit good proteome‐wide selectivity. We verify that the azetidine acrylamides inhibit the catalytic activity of recombinant NSUN2, but not NSUN6, and demonstrate that these compounds stereoselectively disrupt NSUN2‐tRNA interactions in cancer cells, leading to a global reduction in tRNA m 5 C content. Our findings thus highlight the potential to create isotype‐selective and cell‐active inhibitors of NSUN2 with covalent chemistry targeting a conserved catalytic cysteine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550N. Torrey Pines Road, La Jolla, CA-92307, USA.
- LMU Munich, Department of Pharmacy, Butenandtstr. 5-13, 81377, Munich, Germany.
- Department of Chemistry, The University of Chicago, 929 East 57th Street, GCIS E319B, Chicago, IL-60637, USA.
- Current address: Belharra Therapeutics, 3985 Sorrento Valley Blvd Suite C, San Diego, CA-92121, USA.
- Chemical Biology and Therapeutics Science Program, Broad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA-02142, USA.
- Harvard University, Department of Chemistry and Chemical Biology, 12 Oxford Street, MA-02138, Cambridge, USA.
ORCID-Profile: Yongfeng Tao, Jan G Felber, Jarrett R Remsberg, Daisuke Ogasawara, Bruno Melillo, Stuart L Schreiber, Benjamin F Cravatt
Förderung
- NIH HHS
- NHGRI NIH HHS
- NCI NIH HHS
- NIEHS NIH HHS
- National Institutes of Health
Zitieren
APA
Tao, Y., Felber, J. G., Zou, Z., Njomen, E., Remsberg, J. R., Ogasawara, D., Ye, C., Melillo, B., Schreiber, S. L., He, C., Remillard, D., & Cravatt, B. F. (2023). Chemical Proteomic Discovery of Isotype‐Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2. Angewandte Chemie International Edition, 62(51). https://doi.org/10.1002/anie.202311924
Vancouver
Tao Y, Felber JG, Zou Z, Njomen E, Remsberg JR, Ogasawara D, et al. Chemical Proteomic Discovery of Isotype‐Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2. Angewandte Chemie International Edition. 2023;62(51). doi:10.1002/anie.202311924
BibTeX
@article{Tao2023,
author = {Tao, Yongfeng and Felber, Jan G and Zou, Zhongyu and Njomen, Evert and Remsberg, Jarrett R and Ogasawara, Daisuke and Ye, Chang and Melillo, Bruno and Schreiber, Stuart L and He, Chuan and Remillard, David and Cravatt, Benjamin F},
title = {Chemical Proteomic Discovery of Isotype‐Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {51},
doi = {10.1002/anie.202311924}
}
EUVIMED